NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention has expanded a license agreement with Golden Helix for the company’s genetic association software platforms for use in whole-genome association studies, the company said today.
 
The CDC will use the Golden Helix SNP and Variation Suite, including the HelixTree software for population-based studies, the PBAT software for family-based studies, and the CNAM copy number association tool.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.